// App-Quantinova.ai

e21548 : CTLA-4 and PD-1 inhibition in metastatic uveal melanoma: A single center experience.

Researchers

Presenter

  • Vidhya Karivedu

Principal Investigators

  • Abouelmagd Makramalla

  • Zelia Correa

  • Nagla Abdel Karim

Medical Centers

  • University of Cincinnati, Cincinnati, OH

  • University of Cincinnati, Cincinnati, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Programmed cell death protein 1

  • Cytotoxic T-lymphocyte-associated protein 4

Drug/Treatment

  • Ipilimumab

  • Nivolumab

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved